OncoMed Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch OMED and buy or sell other stocks, ETFs, and their options commission-free!About OMED
OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F.
CEOJohn A. Lewicki, PhD
CEOJohn A. Lewicki, PhD
Employees—
Employees—
HeadquartersMountain View, California
HeadquartersMountain View, California
Founded2004
Founded2004
Employees—
Employees—
OMED Key Statistics
Market cap34.41M
Market cap34.41M
Price-Earnings ratio-4.21
Price-Earnings ratio-4.21
Dividend yield—
Dividend yield—
Average volume1.23M
Average volume1.23M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.35
52 Week high$3.35
52 Week low$0.5467
52 Week low$0.5467
Stock Snapshot
As of today, OncoMed Pharmaceuticals(OMED) shares are valued at $0.89. The company's market cap stands at 34.41M, with a P/E ratio of -4.21.
During the trading day, OncoMed Pharmaceuticals(OMED) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for OncoMed Pharmaceuticals(OMED) stock has reached 0, versus its average volume of 1.23M.
Over the past 52 weeks, OncoMed Pharmaceuticals(OMED) stock has traded between a high of $3.35 and a low of $0.55.
Over the past 52 weeks, OncoMed Pharmaceuticals(OMED) stock has traded between a high of $3.35 and a low of $0.55.